Rockwell Medical Inc (NASDAQ:RMTI) was the recipient of some unusual options trading on Thursday. Stock investors bought 3,054 put options on the stock. This is an increase of 3,815% compared to the average daily volume of 78 put options.

Rockwell Medical (RMTI) opened at $5.92 on Friday. The company has a market capitalization of $318.25, a P/E ratio of -13.77 and a beta of 2.02. Rockwell Medical has a 52-week low of $5.06 and a 52-week high of $8.98.

Rockwell Medical (NASDAQ:RMTI) last released its quarterly earnings data on Wednesday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.10). The firm had revenue of $14.63 million for the quarter, compared to analyst estimates of $13.33 million. Rockwell Medical had a negative return on equity of 47.93% and a negative net margin of 34.57%. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.09) earnings per share. equities research analysts anticipate that Rockwell Medical will post -0.44 EPS for the current fiscal year.

A number of large investors have recently added to or reduced their stakes in RMTI. Private Advisor Group LLC bought a new stake in Rockwell Medical in the second quarter valued at approximately $182,000. Wells Fargo & Company MN raised its stake in Rockwell Medical by 12.0% in the second quarter. Wells Fargo & Company MN now owns 129,674 shares of the company’s stock valued at $1,028,000 after buying an additional 13,936 shares during the period. Teachers Advisors LLC raised its stake in Rockwell Medical by 1.5% in the second quarter. Teachers Advisors LLC now owns 88,772 shares of the company’s stock valued at $704,000 after buying an additional 1,335 shares during the period. TIAA CREF Investment Management LLC raised its stake in Rockwell Medical by 1.1% in the second quarter. TIAA CREF Investment Management LLC now owns 132,131 shares of the company’s stock valued at $1,048,000 after buying an additional 1,401 shares during the period. Finally, PNC Financial Services Group Inc. raised its stake in Rockwell Medical by 1,725.7% in the second quarter. PNC Financial Services Group Inc. now owns 15,245 shares of the company’s stock valued at $121,000 after buying an additional 14,410 shares during the period. Hedge funds and other institutional investors own 21.26% of the company’s stock.

Several research analysts recently commented on the company. BidaskClub cut Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Thursday. Zacks Investment Research cut Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Thursday, January 4th.

ILLEGAL ACTIVITY WARNING: This article was reported by Daily Political and is the property of of Daily Political. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.dailypolitical.com/2018/01/20/investors-buy-high-volume-of-rockwell-medical-put-options-rmti.html.

Rockwell Medical Company Profile

Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.